Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

April 7, 2023

Conditions
Atopic Dermatitis
Interventions
DRUG

tapinarof cream, 1%

applied topically once daily

DRUG

Vehicle cream

applied topically once daily

Trial Locations (67)

10075

Dermavant Investigative Site, New York

11530

Dermavant Investigative Site, Garden City

17033

Dermavant Investigative Site, Hershey

20037

Dermavant Investigative Site, Washington D.C.

20774

Dermavant Investigative Site, Largo

23226

Dermavant Investigative Site, Richmond

29615

Dermavant Investigative Site, Greenville

30060

Dermavant Investigative Site, Marietta

30328

Dermavant Investigative Site, Sandy Springs

31406

Dermavant Investigative Site, Savannah

32256

Dermavant Investigative Site, Jacksonville

32801

Dermavant Investigative Site, Orlando

33014

Dermavant Investigative Site, Miami Lakes

33063

Dermavant Investigative Site, Margate

33126

Dermavant Investigative Site, Miami

33146

Dermavant Investigative Site, Coral Gables

33172

Dermavant Investigative Site, Sweetwater

33431

Dermavant Investigative Site, Boca Raton

33486

Dermavant Investigative Site, Boca Raton

33511

Dermavant Investigative Site, Brandon

33615

Dermavant Investigative Site, Tampa

33781

Dermavant Investigative Site, Pinellas Park

35244

Dermavant Investigative Site, Birmingham

37909

Dermavant Investigative Site, Knoxville

40217

Dermavant Investigative Site, Louisville

42301

Dermavant Investigative Site, Owensboro

43209

Dermavant Investigative Site, Bexley

44106

Dermavant Investigative Site, Cleveland

46168

Dermavant Investigative Site, Plainfield

48088

Dermavant Investigative Site, Warren

48197

Dermavant Investigative Site, Ypsilanti

48346

Dermavant Investigative Site, Clarkston

48706

Dermavant Investigative Site, Bay City

55112

Dermavant Investigative Site, New Brighton

59808

Dermavant Investigative Site, Missoula

68144

Dermavant Investigative Site, Omaha

70433

Dermavant Investigative Site, Covington

71201

Dermavant Investigative Site, Monroe

72022

Dermavant Investigative Site, Bryant

73071

Dermavant Investigative Site, Oklahoma City

73120

Dermavant Investigative Site, Oklahoma City

75230

Dermavant Investigative Site, Dallas

77098

Dermavant Investigative Site, Houston

77401

Dermavant Investigative Site, Bellaire

77433

Dermavant Investigative Site, Cypress

77479

Dermavant Investigative Site, Sugar Land

78218

Dermavant Investigative Site, San Antonio

78229

Dermavant Investigative Site, San Antonio

78745

Dermavant Investigative Site, Austin

85032

Dermavant Investigative Site, Phoenix

90017

Dermavant Investigative Site, Los Angeles

90033

Dermavant Investigative Site, Los Angeles

90212

Dermavant Investigative Site, Beverly Hills

90301

Dermavant Investigative Site, Inglewood

92691

Dermavant Investigative Site, Mission Viejo

92708

Dermavant Investigative Site, Fountain Valley

94538

Dermavant Investigative Site, Fremont

95815

Dermavant Investigative Site, Sacramento

97030

Dermavant Investigative Site, Gresham

97223

Dermavant Investigative Site, Portland

R3M 3Z4

Dermavant Investigative Site, Winnipeg

L7L 6W6

Dermavant Investigative Site, Burlington

K9A 0Z4

Dermavant Investigative Site, Cobourg

L8S 1G5

Dermavant Investigative Site, Hamilton

L6J 7W5

Dermavant Investigative Site, Oakville

K2C 3N2

Dermavant Investigative Site, Ottawa

H2X 2V1

Dermavant Investigative Site, Montreal

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT05014568 - Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults | Biotech Hunter | Biotech Hunter